Total Payments
$2,767
2024 Payments
$143.56
Companies
15
Transactions
40
Payment Breakdown by Category
Food & Beverage$2,753 (99.5%)
Education$13.77 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,753 | 39 | 99.5% |
| Education | $13.77 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $682.71 | 9 | $0 (2022) |
| Boston Scientific Corporation | $418.89 | 3 | $0 (2023) |
| Merck Sharp & Dohme LLC | $326.68 | 5 | $0 (2024) |
| Genentech USA, Inc. | $194.72 | 3 | $0 (2024) |
| GlaxoSmithKline, LLC. | $194.56 | 2 | $0 (2019) |
| Abbott Laboratories | $189.26 | 2 | $0 (2019) |
| GENZYME CORPORATION | $150.00 | 1 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $140.78 | 3 | $0 (2019) |
| Tris Pharma Inc | $124.99 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $100.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $143.56 | 4 | Genentech USA, Inc. ($80.92) |
| 2023 | $155.54 | 2 | Boston Scientific Corporation ($131.59) |
| 2022 | $314.89 | 5 | GENZYME CORPORATION ($150.00) |
| 2021 | $112.48 | 1 | BOSTON SCIENTIFIC CORPORATION ($112.48) |
| 2020 | $214.22 | 2 | Janssen Pharmaceuticals, Inc ($120.62) |
| 2019 | $1,003 | 13 | Janssen Pharmaceuticals, Inc ($416.10) |
| 2018 | $264.16 | 4 | Tris Pharma Inc ($124.99) |
| 2017 | $558.92 | 9 | BOSTON SCIENTIFIC CORPORATION ($174.82) |
All Payment Transactions
40 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 06/01/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $80.92 | General |
| Category: Immunology | ||||||
| 04/11/2024 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $20.69 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: VACCINE | ||||||
| 12/20/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $131.59 | General |
| Category: General - Therapies_ENDO | ||||||
| 11/28/2023 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: VACCINE | ||||||
| 08/05/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $46.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/07/2022 | GENZYME CORPORATION | DUPIXENT (Biological), DUPIXENT | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: Immunology | ||||||
| 05/10/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $53.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $46.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL THERAPIES (Device) | Food and Beverage | In-kind items and services | $112.48 | General |
| Category: PAIN MANAGEMENT | ||||||
| 03/09/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $120.62 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/22/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $93.60 | General |
| Category: Virology & Specialty Care | ||||||
| 10/24/2019 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $30.00 | General |
| Category: Cardiovascular | ||||||
| 08/22/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $76.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/08/2019 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $82.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/01/2019 | Merck Sharp & Dohme Corporation | GARDASIL (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: VACCINE | ||||||
| 06/13/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological) | Food and Beverage | In-kind items and services | $97.09 | General |
| Category: VACCINES | ||||||
| 06/11/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $85.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/03/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $105.00 | General |
| Category: Neuroscience | ||||||
| 03/25/2019 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/06/2019 | Abbott Laboratories | Allure CRT Pacemaker (Device) | Food and Beverage | In-kind items and services | $89.42 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/21/2019 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $68.81 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Dr. Wilfredo Rendon, M.D
Dr. Wilfredo Rendon, M.D is a Emergency Medicine healthcare provider based in Hato Rey, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225077944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wilfredo Rendon, M.D has received a total of $2,767 in payments from pharmaceutical and medical device companies, with $143.56 received in 2024. These payments were reported across 40 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($2,753).
Ad
Practice Information
- Specialty Emergency Medicine
- Location Hato Rey, PR
- Active Since 06/06/2006
- Last Updated 03/27/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1225077944
Products in Payments
- XARELTO (Drug) $577.71
- ELIQUIS (Drug) $209.59
- WATCHMAN (Device) $174.82
- DUPIXENT (Biological) $150.00
- Dyanavel XR (Drug) $124.99
- GARDASIL (Biological) $120.00
- Xofluza (Drug) $113.80
- GENERAL THERAPIES (Device) $112.48
- INVEGA SUSTENNA (Drug) $105.00
- INVANZ (Drug) $100.00
- TAGRISSO (Drug) $100.00
- CRT-Ds (Device) $99.84
- SHINGRIX (Biological) $97.47
- BEXSERO (Biological) $97.09
- Allure CRT Pacemaker (Device) $89.42
- ZERBAXA (Drug) $82.73
- Xolair (Biological) $80.92
- TEFLARO (Drug) $58.96
- CLEVIPREX (Drug) $53.36
- GARDASIL 9 (Biological) $23.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.